Orthopedic Splints Market

The market for Orthopedic Splints was estimated at $2.1 billion in 2025; it is anticipated to increase to $3.3 billion by 2030, with projections indicating growth to around $5.3 billion by 2035.

Report ID:DS1801147

Author:Debadatta Patel - Senior Consultant

Published Date:February 2025

Datatree

Life Science

Medical Device

Orthopedic Splints

Customization Available

Orthopedic Splints - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Orthopedic Splints Market Outlook

Revenue, 2025

$2.1B

Forecast, 2035

$5.3B

CAGR, 2026 - 2035

9.5%

The Orthopedic Splints industry revenue is expected to be around $2.1 billion in 2026 and expected to showcase growth with 9.5% CAGR between 2026 and 2035. The increasing clinical and economic importance of orthopedic splints in stabilising fractures and in treating musculoskeletal injuries in the medical sector is reflected in this growing trend. Healthcare professionals are favouring the use of orthopedic splints which are cost effective and efficient. The growing need for orthopedic services is largely due to various factors including higher osteoporosis related fracture risk among an ageing population, increasing volumes of sports injuries and trauma care cases, and improved access to medical care in various regions. The market in the sector for lower and upper limb use is dominated by a small number of large corporations. This accounts for all sales in this sector. It was found that static orthosis products accounted for $1.26 billion in sales in the year 2025. This highlights their importance in recovery procedures following operations. Continuous product development, featuring more ergonomic designs and comfort enhancing features for patients, is enhancing the role of Orthopedic Splints in both hospitals and outpatient surgery facilities and homecare.

Injured limbs are held securely in place by the orthopedic splint, which enables healing by immobilising, supporting and positioning the affected bones, joints and soft tissues. This is done using a variety of materials including air permeable padding and a flexible strapping system. The construction of the splint is also non blocking to X rays. A number of these orthopedic splints are used for the immobilization of both upper and lower limb fractures, injuries of the tendon or ligaments, rehabilitation and post operative immobilization. The orthopedic splints have standardised configurations that allow for immediate use in accident and emergency departments and by paramedics. Advances in orthotics production include bespoke splinting systems that cater to the specific anatomy of patients, longer lasting and more comfortable splint materials and digital design and manufacturing techniques. These technologies all allow for casts that fit better and are put on quicker and enable care that is driven by a specific protocol. The integration of these two advancements in orthopedics is actually bringing about a significant rise in the treatment outcomes of patients, faster healing time and increasing the importance of splints in orthopedics treatment strategies.

Orthopedic Splints market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Orthopedic Splints Market Outlook

Market Key Insights

The Orthopedic Splints market is projected to grow from $2.1 billion in 2025 to $5.3 billion in 2035. This represents a CAGR of 9.5%, reflecting rising demand across Orthopedic Clinic Use, Post-operative Care, and Sports Injuries.
In this market, companies such as 3M, DeRoyal Industries and DJO Global are key players in determining the competitive landscape.
The US and Germany will be the largest markets in the orthopedic splints market and are expected to grow at a compound annual rate of 7.1% to 10.2% between 2024 and 2030.
The countries with the fastest growing markets will be Brazil, India and South Africa with annual growth rates between 9.3% and 12.1%.
By 2030 technological advancements are predicted to increase the orthopedic splints industry value by $321 million.
During the period between 2025 and 2035, the sales of orthopedic splints are anticipated to rise by $3.1 billion. This growth in sales is primarily attributed to manufacturers focusing their efforts on upper extremity applications.
Due to an increase in the number of orthopaedic trauma, and recent developments in the manufacture of orthopaedic splints, sales of orthopaedic splints are due to rise by 152% by 2034 compared to 2024.

Orthopedic Splints - Country Share Analysis

Opportunities in the Orthopedic Splints

Developing countries are upgrading their trauma facilities and regional hospitals, thus creating a requirement for serial static and static progressive orthotics splints to manage contractures and fractures. By 2030, the global static orthotic devices market is also anticipated to reach $0.36 billion from $0.22 billion in 2025, growing at a CAGR of 10.2%. The orthotic devices are categorised into twos static and dynamic. The static devices are further sub classified into static progressive and static. Settings which require emergency and rehabilitation after a trauma or disaster can benefit from low cost prosthetic limb designs, local manufacturing and public private partnerships.

Growth Opportunities in North America and Asia-Pacific

The North American market for orthopedic splints is characterised by its highly developed trauma care services, a high incidence of sports injuries and the burden of chronic health problems. These conditions are mainly addressed by splints used for the lower extremities due to hip and ankle injuries or foot problems related to diabetes. In orthopedic rehabilitation and out patient fracture treatment facilities the sale of upper limb splints for wrist and hand fractures is increasing; leading opportunities include orthopedic care units and the home use of splints that are custom moulded in thermoplastic or can be 3D adjusted. Value engineered products are being produced to meet the demands of contracts based on capitation and bundling payments. Manufacturers of orthopedic devices and those which specialise in sports injury splints are competing intensely, with this competition driving innovations in the use of lighter materials and protocols which have been clinically validated to reduce the time patients are immobilised. Key market drivers in North America include the high number of elective orthopedic procedures which are carried out, insurance cover for health care and the adoption of evidence based medical practice which favours the use of standardised, ready to use splints over traditional casting techniques.

Asia Pacifics orthopaedic splints market is one which is heavily influenced by rapidly urbanising populations, growing road accident statistics and greater access to orthopaedic care. This has the result of lower limb splints holding the highest clinical relevance and sales figures due to the number of patients suffering from leg injuries and falls by the elderly. Manufacturers in industrial region's with high rates of hand injuries are beginning to market upper limb splints. Manufacturers are capitalising on opportunities for cost effective splint portfolios tailored to differents of hospitals. Lower limb splints which are durable are used in emergency trauma care, while upper limb splints which are easy to put on are used in primary healthcare. They are also manufacturing splints for children. These are manufactured locally and distributed to meet the cost constraints of the healthcare system. In the market there is a mix of big orthopaedic brands and smaller regional manufacturers competing on price and how quickly they can supply products to customers. Growth of the market is being driven by developing countries investing in healthcare, an expansion in health insurance coverage, more people becoming aware of the importance of treating fractures early and the benefits of rehabilitation, and the shift away from the use of unorthodox methods of immobilisation to the use of standardised orthopaedic splints in both public and private healthcare systems.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Musculoskeletal Disorders and Increased Sports Participation Among All Age Groups

The growing prevalence of musculoskeletal disorders is also a major driver for orthopedic splints. With an aging global population and higher incidence of conditions such as osteoarthritis, fractures, and joint instability, demand for splints in clinical and home settings has also surged. Healthcare providers emphasize early intervention to manage pain, prevent deformity, and improve mobility, making splints essential in preventive and therapeutic care. Simultaneously, increased participation in sports and recreational activities across demographics has also heightened the incidence of sports‑related injuries such as sprains, strains, and ligament tears. Athletes and active individuals increasingly rely on supportive braces and splints to protect joints, facilitate recovery, and prevent re‑injury. This trend is also mirrored by sports medicine clinics and fitness centers that integrate splints into injury management protocols. Together, these growth factors expand market demand by broadening end‑use scenarios from clinical rehabilitation to active lifestyle support, enhancing adoption rates among orthopedists, physiotherapists, and sports professionals.

A key driver for the orthopedic splints market is also the advancement of lightweight materials and smart splint technologies. Innovations in breathable polymers, carbon fiber composites, and thermoplastics have also produced splints that are also stronger yet lighter, enhancing patient comfort and compliance during prolonged use. At the same time, smart splint solutions equipped with sensors and digital feedback capabilities are also emerging, enabling real‑time monitoring of joint movement, adherence, and rehabilitation progress. These technologies support personalized care regimens, reduce complications from improper use, and provide clinicians with actionable data to adjust treatment plans. As providers adopt these enhanced splint options, the market is also experiencing increased differentiation, higher perceived value, and greater integration into modern care pathways for both clinical and sports applications.

Restraint: High Product Costs

Orthopedic splints are intricate medical tools that need to meet strict quality standards and be made with great precision. Factors that contribute to higher production expenses in turn impacting the final price for consumers burdening them with increased costs and potentially hindering the widespread use of such splints in regions with limited healthcare budgets, like developing countries where market growth is restricted as a result.

Opportunity: Sports medicine and outpatient rehabilitation clinics adopting dynamic Orthopedic Splints for faster, functional recovery worldwide and Rising geriatric fracture burden driving demand for advanced static Orthopedic Splints in global hospitals

In the fields of sports medicine and out patient rehabilitation, dynamic orthopaedic splints are increasing in popularity. They allow for controlled movement and make it possible for patients to return to sport sooner than would be the case with traditional splints. Currently dynamics are a rapidly growing region of development, with their value forecast to grow from $0.46 billion in 2025 to $0.81 billion by the year 2030 at a compound annual growth rate of 11.9%. Among the innovations offered are tele rehabilitation integration, sensors built into the joint, and replaceable parts. Collaborative programmes between orthopaedic surgeons, athletic organisations and physiotherapists can increase the adoption of protocols for ligament repairs and post arthroscopic rehabilitation.

The increasing number of elderly people is a factor that causes an increase in osteoporotic fractures, as a result, the demand for orthopaedic splints in hospitals for treating bone fractures will remain strong. Presently, static splints command the highest sales volume, and their worth is anticipated to increase from $1.26 billion in 2025 to $1.86 billion by the year 2030 at a compound annual growth rate of 8.1 %. Nonetheless, a majority of clinics continue to use plaster casts. The use of lightweight, radiolucent and three dimensionally printed splints can allow for quicker fitting, enhance the management of pressure, and help protect the patients skin in elderly patient care.

Challenge: Regulatory Challenges

Regulatory obstacles in the splints industry present considerable hurdles to overcome. Securing approval from regulators for splints often involves a lengthy and challenging journey that slows down the introduction of innovative products to the market. Furthermore regulatory requirements differ significantly among countries and regions creating additional barriers, for manufacturers aiming to expand globally. These difficulties could impede the splints market from reaching its maximum growth potential.

Supply Chain Landscape

Raw Material Sourcing

3MEssity

Orthopedic Splints Manufacturing

DJO GlobalDeRoyal Industries

Medical Device Distribution

DeRoyal Industriesmedi GmbH & Co. KG

Clinical End Users

HospitalsOrthopedic ClinicsSports Medicine Centers

Raw Material Sourcing

3MEssity

Orthopedic Splints Manufacturing

DJO GlobalDeRoyal Industries

Medical Device Distribution

DeRoyal Industriesmedi GmbH & Co. KG

Clinical End Users

HospitalsOrthopedic ClinicsSports Medicine Centers

Orthopedic Splints - Supply Chain

Use Cases of Orthopedic Splints in Clinic Use & Sports Injuries

Orthopedic Clinic Use : In orthopedic clinics, rigid and semi‑rigid splints such as functional braces, hinged splints, and custom molded orthoses are predominantly used to stabilize fractures, support joint alignment, and assist rehabilitation. These devices provide controlled motion, reduce pain, and promote proper healing in acute and chronic musculoskeletal conditions. Orthopedic specialists rely on splints that balance immobilization with patient comfort. Key market players like Ossur, Breg Inc., DJO Global, and DeRoyal Industries lead this segment with innovative designs, durable materials, and strong clinician trust, reinforcing their positions through extensive product ranges and clinician education programs.

Post-operative Care : Post‑operative care heavily uses post‑surgical splints and immobilizers, including adjustable and padded models that protect surgical sites following fracture fixation, ligament repair, or joint reconstruction. These splints help limit motion to prevent strain on repaired tissues, reduce swelling, and improve patient comfort during the early stages of healing. Hospitals and rehabilitation centers prioritize splints that offer easy application and precise fit. Companies such as Bauerfeind AG, Medi USA, Össur, and BSN Medical dominate this space with high‑quality materials, customizable solutions, and strong distribution networks, enhancing recovery outcomes in clinical practice.

Sports Injuries : For sports injuries, soft and semi‑rigid athletic splints, including wrist, ankle, thumb, and knee braces, are widely used to provide compression, support unstable joints, and prevent further injury during activity. These splints offer flexibility for dynamic movement while reducing the risk of aggravation in sprains, strains, and impact trauma. Athletic trainers and sports medicine clinics favor brands like McDavid, Shock Doctor, DonJoy Performance, and Nike Pro for their ergonomic designs, breathable materials, and sport‑specific performance, making them leaders in the injury prevention and recovery market.

Recent Developments

Recent developments in the orthopedic splints market reflect a shift toward smart orthopedic support and advanced materials that improve patient comfort and rehabilitation outcomes. Manufacturers are integrating sensor technology, breathable thermoplastics, and lightweight composites to enhance compliance and clinical efficacy in fracture management and joint stabilization. A key market trend is the adoption of connected bracing systems that enable remote monitoring and real‑time feedback, supporting personalized recovery plans and expanding the role of digital health in musculoskeletal care.

December 2024 : Johnson & Johnson introduced an advancement, in Orthopedic Splints by unveiling smart splints equipped with biosensors to improve recovery monitoring.

October 2024 : Zimmer Biomet introduced their3D printed Orthopedic Splints aimed at enhancing patient comfort and mobility.

August 2024 : Smith & Nephew has broadened their Orthopedic Splints collection through the purchase of a startup specializing in biodegradable and environmentally friendly splints.

Impact of Industry Transitions on the Orthopedic Splints Market

As a core segment of the Medical Device industry, the Orthopedic Splints market develops in line with broader industry shifts. Over recent years, transitions such as Technological Innovations and Shift towards NonInvasive Treatment Methods have redefined priorities across the Medical Device sector, influencing how the Orthopedic Splints market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Technological Innovations

By the year 2030, 3D printed splints and intelligent orthopaedic splints, the most technologically advanceds, are anticipated to increase the orthopaedic splints market by 321 million U.S. dollars. These customised implants result in improved anatomical fit and comfort. They also enhance patient adherence to treatment and improve clinical results. Their use is seen in both trauma care and post operative rehabilitation from fractures. By integrating digital health capabilities and sensors, remote patient monitoring and data driven care pathways are supported, and providers and payers can benefit from this. The use of new biomaterials and on demand manufacturing is altering cost structures and the supply chain. The changes brought about by technology are transforming the role of orthopedic splints into premium products that offer tailored support to patients. This has helped spur the expansion of the market.

Shift towards NonInvasive Treatment Methods

Many individuals are choosing alternative treatments which avoid surgery for their orthopaedic issues. There is consequently an increased reliance on splints as these devices enable the injured bones and joints to be non surgically stabilised and supported This shift has had considerable implications for healthcare providers as they are expected to take these changing preferences into account when treating patients. Consequently, they are focusing on learning more about non surgical treatments for bones and joints.